nodes	percent_of_prediction	percent_of_DWPC	metapath
Naftifine—SQLE—retina—acquired immunodeficiency syndrome	0.0322	0.141	CbGeAlD
Naftifine—Blister—Nevirapine—acquired immunodeficiency syndrome	0.0264	0.0343	CcSEcCtD
Naftifine—Inflammation—Amprenavir—acquired immunodeficiency syndrome	0.024	0.0311	CcSEcCtD
Naftifine—SQLE—digestive system—acquired immunodeficiency syndrome	0.0226	0.0989	CbGeAlD
Naftifine—Inflammation—Didanosine—acquired immunodeficiency syndrome	0.0218	0.0283	CcSEcCtD
Naftifine—SQLE—spinal cord—acquired immunodeficiency syndrome	0.0207	0.0907	CbGeAlD
Naftifine—SQLE—vagina—acquired immunodeficiency syndrome	0.02	0.0873	CbGeAlD
Naftifine—Inflammation—Nevirapine—acquired immunodeficiency syndrome	0.0196	0.0255	CcSEcCtD
Naftifine—Blister—Efavirenz—acquired immunodeficiency syndrome	0.0195	0.0253	CcSEcCtD
Naftifine—Inflammation—Nelfinavir—acquired immunodeficiency syndrome	0.019	0.0247	CcSEcCtD
Naftifine—Inflammation—Stavudine—acquired immunodeficiency syndrome	0.019	0.0246	CcSEcCtD
Naftifine—SQLE—lung—acquired immunodeficiency syndrome	0.0189	0.0826	CbGeAlD
Naftifine—Inflammation—Abacavir—acquired immunodeficiency syndrome	0.0187	0.0242	CcSEcCtD
Naftifine—Blister—Delavirdine—acquired immunodeficiency syndrome	0.0186	0.0242	CcSEcCtD
Naftifine—SQLE—nervous system—acquired immunodeficiency syndrome	0.0175	0.0765	CbGeAlD
Naftifine—SQLE—central nervous system—acquired immunodeficiency syndrome	0.0168	0.0736	CbGeAlD
Naftifine—Inflammation—Indinavir—acquired immunodeficiency syndrome	0.0153	0.0199	CcSEcCtD
Naftifine—Inflammation—Efavirenz—acquired immunodeficiency syndrome	0.0145	0.0188	CcSEcCtD
Naftifine—Dermatitis bullous—Nevirapine—acquired immunodeficiency syndrome	0.0145	0.0188	CcSEcCtD
Naftifine—Dermatitis bullous—Nelfinavir—acquired immunodeficiency syndrome	0.014	0.0182	CcSEcCtD
Naftifine—Inflammation—Delavirdine—acquired immunodeficiency syndrome	0.0139	0.018	CcSEcCtD
Naftifine—SQLE—brain—acquired immunodeficiency syndrome	0.0134	0.0584	CbGeAlD
Naftifine—SQLE—lymph node—acquired immunodeficiency syndrome	0.0129	0.0565	CbGeAlD
Naftifine—Inflammation—Saquinavir—acquired immunodeficiency syndrome	0.0123	0.016	CcSEcCtD
Naftifine—Swelling—Indinavir—acquired immunodeficiency syndrome	0.0122	0.0159	CcSEcCtD
Naftifine—Inflammation—Lamivudine—acquired immunodeficiency syndrome	0.0118	0.0152	CcSEcCtD
Naftifine—Agranulocytosis—Didanosine—acquired immunodeficiency syndrome	0.0111	0.0143	CcSEcCtD
Naftifine—Swelling—Delavirdine—acquired immunodeficiency syndrome	0.0111	0.0143	CcSEcCtD
Naftifine—Dermatitis bullous—Efavirenz—acquired immunodeficiency syndrome	0.0107	0.0138	CcSEcCtD
Naftifine—Dermatitis bullous—Delavirdine—acquired immunodeficiency syndrome	0.0102	0.0132	CcSEcCtD
Naftifine—Agranulocytosis—Nevirapine—acquired immunodeficiency syndrome	0.00994	0.0129	CcSEcCtD
Naftifine—Dermatitis bullous—Ritonavir—acquired immunodeficiency syndrome	0.00944	0.0122	CcSEcCtD
Naftifine—Dermatitis bullous—Saquinavir—acquired immunodeficiency syndrome	0.00908	0.0118	CcSEcCtD
Naftifine—SIGMAR1—blood—acquired immunodeficiency syndrome	0.00901	0.0394	CbGeAlD
Naftifine—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.00872	0.0382	CbGeAlD
Naftifine—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.00868	0.038	CbGeAlD
Naftifine—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.00835	0.0366	CbGeAlD
Naftifine—Agranulocytosis—Zidovudine—acquired immunodeficiency syndrome	0.00834	0.0108	CcSEcCtD
Naftifine—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00833	0.0108	CcSEcCtD
Naftifine—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.00829	0.0107	CcSEcCtD
Naftifine—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00806	0.0105	CcSEcCtD
Naftifine—SIGMAR1—lung—acquired immunodeficiency syndrome	0.0079	0.0346	CbGeAlD
Naftifine—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00722	0.00936	CcSEcCtD
Naftifine—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.0072	0.00933	CcSEcCtD
Naftifine—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.00709	0.00919	CcSEcCtD
Naftifine—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00699	0.00906	CcSEcCtD
Naftifine—Pain—Didanosine—acquired immunodeficiency syndrome	0.00646	0.00838	CcSEcCtD
Naftifine—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00625	0.00811	CcSEcCtD
Naftifine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00614	0.00796	CcSEcCtD
Naftifine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.00596	0.00772	CcSEcCtD
Naftifine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00587	0.00762	CcSEcCtD
Naftifine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00587	0.0076	CcSEcCtD
Naftifine—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00581	0.00753	CcSEcCtD
Naftifine—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00563	0.0073	CcSEcCtD
Naftifine—Pain—Stavudine—acquired immunodeficiency syndrome	0.00561	0.00727	CcSEcCtD
Naftifine—SIGMAR1—brain—acquired immunodeficiency syndrome	0.00559	0.0245	CbGeAlD
Naftifine—Pain—Abacavir—acquired immunodeficiency syndrome	0.00553	0.00717	CcSEcCtD
Naftifine—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.0054	0.0236	CbGeAlD
Naftifine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00535	0.00693	CcSEcCtD
Naftifine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00526	0.00682	CcSEcCtD
Naftifine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00523	0.00678	CcSEcCtD
Naftifine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00523	0.00678	CcSEcCtD
Naftifine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00522	0.00677	CcSEcCtD
Naftifine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00519	0.00673	CcSEcCtD
Naftifine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00499	0.00647	CcSEcCtD
Naftifine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00488	0.00632	CcSEcCtD
Naftifine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00486	0.0063	CcSEcCtD
Naftifine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00481	0.00623	CcSEcCtD
Naftifine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00477	0.00618	CcSEcCtD
Naftifine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00476	0.00617	CcSEcCtD
Naftifine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00473	0.00614	CcSEcCtD
Naftifine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00468	0.00607	CcSEcCtD
Naftifine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00466	0.00604	CcSEcCtD
Naftifine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00464	0.00602	CcSEcCtD
Naftifine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00457	0.00593	CcSEcCtD
Naftifine—Pain—Indinavir—acquired immunodeficiency syndrome	0.00454	0.00588	CcSEcCtD
Naftifine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00447	0.00579	CcSEcCtD
Naftifine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00435	0.00564	CcSEcCtD
Naftifine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00434	0.00562	CcSEcCtD
Naftifine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00429	0.00555	CcSEcCtD
Naftifine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00428	0.00555	CcSEcCtD
Naftifine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00428	0.00555	CcSEcCtD
Naftifine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00427	0.00554	CcSEcCtD
Naftifine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00426	0.00552	CcSEcCtD
Naftifine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00415	0.00538	CcSEcCtD
Naftifine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00415	0.00537	CcSEcCtD
Naftifine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00414	0.00536	CcSEcCtD
Naftifine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00413	0.00536	CcSEcCtD
Naftifine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00412	0.00534	CcSEcCtD
Naftifine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00411	0.00533	CcSEcCtD
Naftifine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.0041	0.00531	CcSEcCtD
Naftifine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00408	0.00528	CcSEcCtD
Naftifine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00407	0.00528	CcSEcCtD
Naftifine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00405	0.00525	CcSEcCtD
Naftifine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00403	0.00523	CcSEcCtD
Naftifine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00379	0.00491	CcSEcCtD
Naftifine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00377	0.00489	CcSEcCtD
Naftifine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00375	0.00486	CcSEcCtD
Naftifine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00365	0.00473	CcSEcCtD
Naftifine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.0036	0.00466	CcSEcCtD
Naftifine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00359	0.00466	CcSEcCtD
Naftifine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00357	0.00463	CcSEcCtD
Naftifine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00355	0.0046	CcSEcCtD
Naftifine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00351	0.00455	CcSEcCtD
Naftifine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00348	0.00451	CcSEcCtD
Naftifine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00339	0.0044	CcSEcCtD
Naftifine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00334	0.00433	CcSEcCtD
Naftifine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00334	0.00433	CcSEcCtD
Naftifine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00332	0.00431	CcSEcCtD
Naftifine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00331	0.0043	CcSEcCtD
Naftifine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00317	0.00411	CcSEcCtD
Naftifine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00316	0.0041	CcSEcCtD
Naftifine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00316	0.00409	CcSEcCtD
Naftifine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00314	0.00407	CcSEcCtD
Naftifine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00314	0.00407	CcSEcCtD
Naftifine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00302	0.00392	CcSEcCtD
Naftifine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00302	0.00392	CcSEcCtD
Naftifine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00302	0.00391	CcSEcCtD
Naftifine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.003	0.00389	CcSEcCtD
Naftifine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00293	0.0038	CcSEcCtD
Naftifine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00288	0.00373	CcSEcCtD
Naftifine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00282	0.00366	CcSEcCtD
Naftifine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.0028	0.00362	CcSEcCtD
Naftifine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00279	0.00362	CcSEcCtD
Naftifine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00278	0.0036	CcSEcCtD
Naftifine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00269	0.00349	CcSEcCtD
Naftifine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00269	0.00349	CcSEcCtD
Naftifine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00269	0.00348	CcSEcCtD
Naftifine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00267	0.00347	CcSEcCtD
Naftifine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00257	0.00333	CcSEcCtD
Naftifine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00256	0.00332	CcSEcCtD
Naftifine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00255	0.00331	CcSEcCtD
